Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril, spironolactone and carvedilol in breast cancer patients receiving chemotherapy
IRCT2017061034432N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of captopril, spironolactone and carvedilol in breast cancer, sponsored by Isfahan University of Medical Sciences. Started Mar 2018; status: completed.
02
Drugs
captoprilspironolactonecarvedilol
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT2017061034432N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017061034432N1.